Page 205 - product-manual
P. 205

TM/MC  TM/MC
             PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





                               Selenium (L-Selenomethionine)

                               Humans  and  animals  require  selenium  for  the  function  of  a  number  of  selenium-dependent
                               enzymes,  also  known  as  selenoproteins.  During  selenoprotein  synthesis,  selenocysteine  is
                               incorporated into a very specific location in the amino acid sequence in order to form a functional
                               protein. At least 25 selenoproteins have been identified, but the metabolic functions have been
                               identified for only about one-half of them. The selenoproteins with an identified function include:
                               glutathione peroxidises which are antioxidant enzymes (Gladyshev, 2006); thioredoxin reductase
                               which participates in the regeneration of several antioxidants including vitamin C (Mustacich
                               &  Powis,  2000);  iodothyronine  deiodinases  involved  in  the  regulation  of  thyroid  hormones
                               (Hatfield et al., 2006); selenoprotein P, associated with protection of vascular endothelial cells
                               against reactive nitrogen species (Arteel et al., 1999); selenoprotein W, thought to play a role in
                               muscle growth and differentiation by protecting the developing myoblast from oxidative stress
                               (Loflin et al. 2006); selenoprotein V functions in spermatogenesis; selenoprotein S is involved
                               with  inflammatory  and  immune  responses;  kDA  selenoprotein  has  a  redox  function  and  is
                               implicated in cancer prevention (Gladyshev, 2006). Animal studies indicate that selenium and
                               vitamin E tend to spare one another and that selenium can prevent some of the damage resulting
                               from vitamin E deficiency in models of oxidative stress (Sword et al., 1991). Only one paper reports
                               experimentally produced clinical signs of selenium deficiency in dogs; there are no reports for
                               cats. Clinical signs include anorexia, depression, dyspnea, and coma (NRC, 2006).



                 Toxicity for selenium has not been documented in dogs and cats when administered orally in therapeutic doses.
            TOXICOLOGY  Parenteral selenium products are also quite toxic, especially to young animals, and have caused deaths in baby
                 However, a single acute oral dose of selenium in the range of 1-5 mg/kg of body weight is lethal in most animals.

                 pigs, calves, and dogs at doses as low as 1.0 mg/kg of body weight (Kahn & Line, 2010). Oral LD  for sodium
                                                                                                    50
                 selenite is 1.0 mg/kg in rabbits, 3.0 mg/kg of body weight in mice and 4.8-7.0 mg/kg of body weight in rats
                 (EMEA, 1997). Vitamin E exhibits a protective effect on selenium intoxication (Berschneider et al., 1976).


                   DRUG    Validated interactions studies do not exist for selenium preparations. However, the anticonvulsant
          INTERACTIONS     medication valproic acid has been found to decrease plasma selenium levels. Animal studies have
                           found that supplemental sodium selenite decreases the toxicities of the antibiotic nitrofurantoin
                           (Flodin, 1990).





















        20 |   VimForte -VM TM
   200   201   202   203   204   205   206   207   208   209   210